MENA AI-based Clinical Trials Solution Provider Market (Clinical Trial Phase - Phase-I, Phase-II, and Phase-III; Therapeutic Application - Cancer, Cardiovascular Disease, Neurological Disease, Metabolic Disease, Infectious Disease, and Others): Industry Analysis, Trends, Size, Share and Forecasts to 2028

1.      Preface

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

2.      Executive Summary

2.1.   AI-based Clinical Trials Solution Provider Market Highlights

2.2.   AI-based Clinical Trials Solution Provider Market Projection

2.3.   AI-based Clinical Trials Solution Provider Market Country Highlights

3.      MENA AI-based Clinical Trials Solution Provider Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1.      Drivers

3.2.2.      Restraints

3.2.3.      Opportunities

3.3.   Analysis of COVID-19 impact on the AI-based Clinical Trials Solution Provider Market

3.4.   Porter's Five Forces Analysis

3.5.   IGR-Growth Matrix Analysis

3.5.1.      IGR-Growth Matrix Analysis by Clinical Trial Phase

3.5.2.      IGR-Growth Matrix Analysis by Therapeutic Application

3.5.3.      IGR-Growth Matrix Analysis by Country

3.6.   Value Chain Analysis of AI-based Clinical Trials Solution Provider Market

4.      MENA AI-based Clinical Trials Solution Provider Market by Clinical Trial Phase

4.1.   Phase-I

4.2.   Phase-II

4.3.   Phase-III

5.      MENA AI-based Clinical Trials Solution Provider Market by Therapeutic Application

5.1.   Cancer

5.2.   Cardiovascular Disease

5.3.   Neurological Disease

5.4.   Metabolic Disease

5.5.   Infectious Disease

5.6.   Others

6.      MENA AI-based Clinical Trials Solution Provider Market by Country 2022-2028

6.1.   Middle East

6.1.1.      Middle East AI-based Clinical Trials Solution Provider Market by Clinical Trial Phase

6.1.2.      Middle East AI-based Clinical Trials Solution Provider Market by Therapeutic Application

6.1.3.      Middle East AI-based Clinical Trials Solution Provider Market by Country

6.2.   North Africa

6.2.1.      North Africa AI-based Clinical Trials Solution Provider Market by Clinical Trial Phase

6.2.2.      North Africa AI-based Clinical Trials Solution Provider Market by Therapeutic Application

6.2.3.      North Africa AI-based Clinical Trials Solution Provider Market by Country

7.      Company Profiles and Competitive Landscape

7.1.   Competitive Landscape in the MENA AI-based Clinical Trials Solution Provider Market

7.2.   Companies Profiles

7.2.1.      Unlearn AI Inc

7.2.2.      Saama Technologies, Inc

7.2.3.      Deep 6 AI

7.2.4.      Innoplexus

7.2.5.      Symphony AI

7.2.6.      Mendel.ai

7.2.7.      AiCure

7.2.8.      Ardigen

7.2.9.      BioSymetrics

7.2.10.  GNS Healthcare